Pain Study Using Intermittent Bupivacain Injections After Breast Reconstruction With DIEP Flap

patients are given bupivacain intermittent locally on the donor site after brest reconstruction with diep flap. The hypothesis was that this approach will reduce the need for rescue analgetic medication and pain perception within the three first days

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Breast Reconstruction Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms

Sex eligibility

Female

Study type

Interventional

Phase

Phase 2

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

all patients planned to undergo reconstructive breast surgery with a DIEP

Exclusion criteria

regular use of analgesics
known allergic reaction to bupivacain
bleeding disorders
pregnancy

Treatment and study plan

Bupivacain

Drug

Placebo

Drug

Sponsors and collaborators

Lead sponsor

Ullevaal University Hospital

Other

Registry information

Official study title

Improved Pain Relief Using Intermittent Bupivacain Injections at the Donor Site After Breast Reconstruction With Deep Inferior Epigastric Artery Perforator (DIEP) Flap

Important dates

Study start: 2005
Primary completion: 2007
Study completion: 2007
First posted: Dec 9, 2008
Registry last updated: Jul 1, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed